Skip to main content

3E Bioventures — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

41
Companies
$842.4M
Total invested
$20.1M
Avg. check
17
Industries
Health Care 12Biotechnology 11Medical 9Therapeutics 5Biopharma 4Pharmaceutical 3+11 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–41 of 41
Myrobalan Therapeutics
March 2025

Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.

Biotechnology · Medford$850K Grant
Jushu Biotech
April 2024

Jushu Biotech is a medical engineering company that focuses on the research and development of synthetic biosensing technology.

Biopharma · ChangpingSeries A
varnotech
March 2024

Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses.

Intellectual Property · Beijing$83.0M Series B
Ligatech Bioscience
September 2023

Ligatech Bioscience is an intrusive consumables developer .

Biotechnology · QingpuSeries D
Eluminex Biosciences
August 2023

Eluminex Biosciences is dedicated to the research and commercialization of novel therapies to address unmet medical needs.

Health Diagnostics · Suzhou$10.0M Series B
Eaglenos
May 2023

Eaglenos is an IVD firm that specializes in medical POCT, home health care products, and health management systems.

Health Care · Nanjing$21.2M Series A
Larkspur Biosciences
May 2023

Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.

Biotechnology · Watertown$35.5M Series A
Cullgen
May 2023

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

Biotechnology · San Diego$35.0M Series C
Boaoxin
April 2023

Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.

Biopharma · Nanjing$1K Series B
Apexigen
January 2023

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Biopharma · San Carlos$2.8M Post Ipo Equity
Regenacy Pharmaceuticals
August 2022

Regenacy Pharmaceuticals Provides Healthcare Services.

Biotechnology · Waltham$9.3M Series B
Zhengli Technology
December 2021

Zhengli Technology is a medical technology company engaged in the research, production, and sales of invisible orthodontic products.

Dental · Tianjin$15.7M Series C
ITabMed
December 2021

ITabMed's aim of "Innovating for Life" continues, with a focus on the discovery and development of cancer immunotherapy treatments.

Biopharma · Shanghai$20.0M Series A
NeuralGalaxy
August 2021

NeuralGalaxy is a brain science company which is devoted to solve brain disorders.

Health Care · Boston$77.3M Series A
Doctor Shaoyang
August 2019

Doctor Shaoyang is a Provider of a medical platform

Consulting · Guangzhou$7.1M Series A
Refuge Biotechnologies
May 2018

Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.

Biotechnology · Menlo Park$25.0M Series B
Eucure Biopharma
March 2018

Eucure Biopharma is a biotechnology company that develops immuno-oncology targeted antibodies.

Biotechnology · Beijing$19.1M Series B

Where 3E Bioventures invests

Health Care12
Biotechnology11
Medical9
Therapeutics5
Biopharma4
Pharmaceutical3

About 3E Bioventures's portfolio

How many companies has 3E Bioventures invested in?▸

3E Bioventures has invested in 41 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does 3E Bioventures invest in?▸

3E Bioventures's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Biopharma. The firm invests across 17 different industry categories.

What is 3E Bioventures's largest investment?▸

Among tracked funding rounds, varnotech received $83.0M in a Series B round. 3E Bioventures's total known invested capital is $842.4M.

What is the average investment size for 3E Bioventures?▸

3E Bioventures's average investment size is $20.1M across its portfolio of 41 companies.

What are 3E Bioventures's most recent investments?▸

Recent 3E Bioventures portfolio additions include Myrobalan Therapeutics, Jushu Biotech, varnotech, Ligatech Bioscience, Eluminex Biosciences. These companies were founded in 2020 or later.

Reach the founders behind these 41 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →